Brief outcome of five decades of battle with infectious diseases in Iran
| Autor: | Nima Mohammadzadeh, Vahid Lohrasbi, Neda Shirmohammadlou |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Strategic planning
System development Economic growth Battle Middle East business.industry media_common.quotation_subject education Vaccination Infection disease Infectious Diseases Infectious disease (medical specialty) Virology Commentary population characteristics Human resources business geographic locations media_common |
| Zdroj: | Virusdisease |
| ISSN: | 2347-3517 2347-3584 |
| Popis: | According to WHO health profile, Iran has better situation in controlling some infection disease like leprosy, dengue fever, tularemia and hepatitis B than United States, even though Iran is in a more dangerous area than the USA. Achieving optimum control for infectious disease in the Middle East requires huge financial costs, equipment and a great time. Some of Iran’s actions to control infectious diseases include: special attention of the Iran government to the health issue, training and developing human resources, membership and close cooperation with international organizations like WHO, detecting and monitoring emerging diseases before their arrival and distribution in Iran, expanding and updating national immunization and vaccination program since 1992, national project implementation titled “Health system development plan”, supplying and manufacturing most of drugs required in Iran by the Iranian companies as a strategic planning, great coordination between different departments of the MOHME and other relevant institutions to Iran Army and Ministry of Intelligence to prevent the emergence of bioterrorism, and etc. We believe that Iran has obtained an acceptable score in the control of infectious diseases; but it still has very big challenges to reach the ideal level. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink